Global Coronary Stent Market Report: 2010 Edition

Date: August 22, 2010
Pages: 36
US$ 800.00
Publisher: Koncept Analytics
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: G22C0C78246EN

Download PDF Leaflet

Global Coronary Stent Market Report: 2010 Edition
The market for coronary stents is one of the fastest growing markets in the medical devices industry. After registering a remarkable growth from 2002 to 2006, the revenues from global coronary stents market declined thereafter. Due to the appeal for less invasive percutaneous coronary intervention procedures and advances in technology, the global coronary stents market is forecasted to grow at a CAGR of 3.7%.

Coronary artery disease is one of the leading causes of death worldwide. The treatment of coronary artery disease includes alternative treatment methodologies, that is, coronary artery bypass grafting or angioplasty (percutaneous coronary intervention) with or without stenting. The percutaneous coronary intervention procedures involving drug-eluting stents are being increasingly used to treat complex coronary artery diseases with an almost 65% penetration rate in 2009.

In the global coronary stent market, the US market for drug eluting stents is the largest market followed by Japan and China, which are also the largest markets in Asia Pacific. Collectively, the US and Japan accounted for more than half of the global drug eluting stents market in 2009. The leading coronary stent manufacturers are Boston Scientific, Johnson & Johnson/Cordis, Abbott Labs and Medtronic.

Due to the growing demand for minimally invasive procedures and the introduction of drug-eluting stents, there has been a rapid increase in the coronary stents market in the past few years. The growth in the market is being primarily driven by the increase in the elderly population, obesity rates, advances in technology, such as the emergence of bio absorbable stents and other new generation stents.

The report analyzes the coronary stent market from two perspectives. One is from the point of products, i.e., BMS and DES market size and growth rate and second is the size of the main regional stents market, like, the US, China, and Japan. It also discusses the major factors driving the market along with the new developments in the market.

By combining SPSS Inc.’s data integration and analysis capabilities with our relevant findings, we have predicted the future growth of the industry. We employed various significant variables that have an impact on this industry and created regression models with SPSS Base to determine the future direction of the industry. Before deploying the regression model, the relationship between several independent or predictor variables and the dependent variable was analyzed using standard SPSS output, including charts, tables and tests.

Types of Stents
Bare Metal Stents
Drug Eluting Stents
Benefits of Stenting Procedure


2.1 Global Market
  Market Value
  PCI Procedure Growth
  Penetration Rate
2.2 Regional Markets
  2.2.1 United States Coronary Stent
    Market Value
    PCI Procedure Growth
    DES Penetration Rate
  2.2.2 China Coronary Stent
    Market Value
    PCI Procedure Growth
    Market Share
  2.2.3 Japan Coronary Stent
  2.2.4 United Kingdom Coronary Stent
2.3 Coronary Stent Market by Stent Types
  2.3.1 Bare Metal Stents
  2.3.2 Drug Eluting Stents


3.1 Market Drivers
  Smoking – A Key Driver
  Obesity Rates
  Elderly Population
  Advances in Technology
3.2 Market Developments
  Bioabsorbable Stents
  Next generation Drug Eluting Stents


Global Market
US Market


5.1 Boston Scientific
  Company Overview
  Key Financials
  Business Strategies
  Business Restructuring Initiatives
  Expansion of Global Market Share
  Research and Development
5.2 Cordis Corporation
  Company Overview
  Key Financials
  Business Strategies
  Developing Innovative Products
  Intensifying Global Presence through Acquisitions
5.3 Abbott
  Company Overview
  Key Financials
  Business Strategies
  Realigning Manufacturing and R&D Operations
  Diversification of Business
5.4 Medtronic
  Company Overview
  Key Financials
  Business Strategies
  Global Realignment Initiative
  Focus on Emerging Markets for Growth


6.1 Market Forecast
6.2 Forecast Methodology
  6.2.1 Dependent and Independent Variables
  6.2.2 Correlation Analysis
  6.2.3 Regression Analysis


Global Stent Market Revenue Growth, 2000-2009
Global PCI Procedures, 2005-2012E
Global Drug Eluting Stent Penetration Rates, Q107-Q309
US Total Stents and DES Market Size, 2005-2012E
Growth of PCI Procedures in US, 2005-2012E
US DES Penetration Rate, Q108-Q110
US Market Share of Leading Players in DES Market, 2009E
PCI Procedures in China, 2000-2012F
China DES Market Size, 2008-2014
China Market Share by Revenue, 2008
Japan’s DES Market Size, 2004-2010F
Growth of PCI Procedures Vs CABG in UK, 2000-2007
Worldwide Bare Metal Stent Sales, 1994-2011E
Worldwide Drug Eluting Stent Sales, 2002-2011E
Global Drug Eluting Stents Market Size, 2009
Market Shares of Leading Players in BMS Market, 2009E
Market Shares of Leading Players in DES Market, 2009E
Global Market Share for Different DES Players, 2008-2010E
US Market Shares for Different DES Players, 2Q09-4Q09
Sales Growth of Boston Scientific, 2005-2009
Sales Growth of Cordis, 2006-2009
Sales Growth of Abbott Labs, 2006-2009
Sales Growth of Medtronic, 2006-2009
Global Coronary Stent Market Revenue Growth, 2002-2012F


Drug Eluting Stents under Development
Currently Available Drug Eluting Stents in the Market
Dependent & Independent Variables (2002– 2009)
Correlation Matrix
Model Summary – Coefficient of Determination
Regression Coefficients Output
Skip to top

Ask Your Question

Global Coronary Stent Market Report: 2010 Edition
Company name*:
Contact person*:
Request invoice
Your enquiry:
Please click on a Check Box below to confirm you are not a robot: